Cognetivity Neurosciences (1UB) Stock Statistics & Valuation Metrics

Cognetivity Neurosciences has a market cap or net worth of €557.77K. The enterprise value is ―.

Cognetivity Neurosciences has 89,588,610 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cognetivity Neurosciences’s return on equity (ROE) is 0.75 and return on invested capital (ROIC) is 97.17%.

The current PE Ratio of Cognetivity Neurosciences is ―. Cognetivity Neurosciences’s PEG ratio is ―.

In the last 12 months, Cognetivity Neurosciences had revenue of 45.37K and earned -7.43M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -3.85M and capital expenditures -28.55K, giving a free cash flow of -3.88M billion.

Cognetivity Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Cognetivity Neurosciences upcoming earnings date is Dec 20, 2024, TBA (Confirmed).

Cognetivity Neurosciences as a current ratio of 0.25, with Debt / Equity ratio of -13.05%

In the past 12 months, Cognetivity Neurosciences has paid 0.00 in taxes.

Cognetivity Neurosciences EV to EBITDA ratio is -3.10, with an EV/FCF ratio of -3.29.

Cognetivity Neurosciences has €16.57K in cash and marketable securities with €2.74M in debt, giving a net cash position of -€2.72M billion.

Gross margin is 45.70%, with operating margin of -13866.36%, and net profit margin of -16386.31%.

The average price target for Cognetivity Neurosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―